This article could do with a bit of a reorganization: it moves freely from talking about naturally occurring melatonin to talking about melatonin taken as a sleep aid/dietary supplement. It's generally clear from context that, for example, the safety section is about the supplement... but other parts aren't as clear. -- Starwed 05:23, 1 October 2007 (UTC)
In the section on “biological clock” I intend to add this sentence immediately following “but over-illumination can create significant reduction in melatonin production.”; “Since it is blue light that suppresses melatonin (ref. 1) , wearing glasses that block blue light (ref. 2)in the evening can help maintain melatonin production.” The first reference is to Brainard’s 2001 paper PMID: 11487664 that identifies blue light as the cause of melatonin suppression and the second reference is to Kayumov’s paper PMID: 15713707 in which he showed glasses that block blue light allow melatonin to flow, despite exposure to bright light. Are there any objections to my doing so? Rhansler 13:54, 2 November 2007 (UTC) Rhansler
In view of the above I think I will add a qualifying word along with blue light to read "principally blue light". Rhansler Rhansler 02:41, 5 November 2007 (UTC) Rhansler —Preceding unsigned comment added by Rhansler ( talk • contribs) 21:39, 4 November 2007 (UTC)
If I put in in this format will it work? Since it is principally blue light that suppresses melatonin PMID: 11487664, wearing glasses that block blue light PMID: 15713707 in the hours before bedtime can help maintain melatonin production. Rhansler 18:26, 6 November 2007 (UTC) Rhansler
I feel that this section is oddly misplaced at the end instead of near the beginning of the article. Melatonin plays a tremendous role wrt seasonality, reproduction etc in many animals. The section looks like an afterthought. It would IMO be better moved to right after Production and Distribution.
Its name is perhaps a bit odd, too. Role in the study of zoology, or role in the animal kingdom? Hordaland 09:43, 5 November 2007 (UTC)
The John Hammell reference may be seriously meant, but it reads like a parody. The following article from The Independent may be a better (as well as newer) source: http://news.independent.co.uk/health/article118214.ece Hordaland 18:35, 8 November 2007 (UTC)
The primary basic funtion of melatonin is not that of an anti-oxidant. Many related molecules can exert similar anti-oxidant activity (Proc Natl Acad Sci U S A. 1990 Apr;87(7):2506-10. Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases.Christen S, Peterhans E, Stocker R.
The basic melatonin function is to tell the body the time of the day and of the year by acting on high affinity receptors. Accordin to the existing evidence, melatonin is just one of the many anti-oxidant molecules —Preceding unsigned comment added by 193.246.191.129 ( talk) 13:54, 22 November 2007 (UTC)
A paragraph, see below, was recently added to the Biological Clock (in humans) section about melatonin's effect on the hormone Leptin and on appetite. This was sadly misplaced. I added a short mention of and link to Leptin in the section on the animal kingdom and added (moved) the reference to the article on Leptin. If more of the removed paragraph should appear in the Melatonin article, it should be added in a relevant section. The removed paragraph was this:
Affects on Appetite: Leptin is a hormone that is synthesized in adipose tissue that is produced in direct proportion to fat stores within the body. Elevated levels of serum leptin result in a decrease in appetite. Melatonin receptors have been found in adipose tissue which, upon stimulation by melatonin acting in concert with insulin, increase production of leptin (Alonso-Vale, M.I., Andreotti, S., Peres, S.B., Anhe, G.F., Borges-Silva, C.N., Neto, J.C. & Lima, F.B. (2004). American Journal of Physiology-Endocrinology and Metabolism: November 30, 2004. Retrieved Dec. 15, 2007 from http://ajpendo.physiology.org/cgi/content/short/00478.2004v1.). Therfore, the net effect is that elevated levels of melatonin decrease appetite. —Preceding unsigned comment added by Hordaland ( talk • contribs) 22:55, 15 December 2007 (UTC)
It would be good if someone could find a source for this. The article said that melatonin was not available over-the-counter in the EU. An anon has recently changed this, commenting "Melatonin is sold OTC in many EU countries". I know that it's not OTC in Sweden nor UK. How to find out if there's an EU policy on this? Or a listing of other countries outside of EU? -- Hordaland ( talk) 19:20, 5 January 2008 (UTC)
Yes, As far as I know it is not OTC in the UK. SpangleJ - UK
Spanglej (
talk) 20:19, 5 April 2009 (UTC)
The article mentions that tinted glasses can be worn in order to promote melatonin production. I believe, however, that the melatonin-light interaction occurs in all the skin, so mostly has nothing to do with the eyes. Would someone with more knowledge confirm or deny my suspicion? —Preceding unsigned comment added by 75.31.242.30 ( talk) 04:30, 6 January 2008 (UTC)
This article is now the new Pharmacology Collaboration of the Month. Hopefully, it can be improved to featured or good article status. Dr. Cash ( talk) 17:32, 14 January 2008 (UTC)
Melatonin taken in combination with monoamine oxidase inhibitors (MAOIs) can lead to overdose because MAOIs inhibit the breakdown of melatonin by the body.[citation needed]
Removing this sentence. It's been discussed since 12/05 December 2005 (see above archive), and still no source. It's also not entirely clear on overdose of what? Overdosing on melatonin is unheard of. --
Hordaland (
talk) 00:01, 17 January 2008 (UTC)
The International Agency for Research on Cancer, announced through a press release in December 2007 that shiftwork that involves circadian disruption is “probably carcinogenic to humans”.
They reviewed epidemiological studies of long-term female night shiftworkers and noted a higher risk of breast cancer risk than those who did not work at night. These studies have involved mainly nurses and flight attendants. Animal studies had similar results where light at night significantly increased tumours. This relates to melatonin in that studies reducing levels of this hormone at night increased the tumours.
The IARC committee head noted that nearly 20% of the working population in Europe and North America are engaged in shiftwork, with many workers in health-care and transportation fiels as well as in industrial, communications, and hospitality sectors. Studies focussed on breast cancer in nurses and flight attendants.
70.51.93.236 ( talk) 00:16, 24 February 2008 (UTC)Lorraine Davison 70.51.93.236 ( talk) 00:16, 24 February 2008 (UTC)
{{
cite journal}}
: Unknown parameter |coauthors=
ignored (|author=
suggested) (
help)"Until recent history, humans in temperate climates were exposed to up to 18 hours of darkness in the winter" Didn't people gather around camp fires for lighting and warmth in the winter? -- Phenylalanine ( talk) 21:08, 1 March 2008 (UTC)
Greetings,
I posted an external link and it was deleted. I would respectfully like to request feedback on this.
The link was on melatonin and insomnia.
I felt it was valuable because the article to which I linked:
The user who deleted it said it "Violates WP:COI, WP:ADVERT, etc." I understand this point of view but respectfully disagree with it. I am connected with the magazine that published the article, but I am not going around posting arbitrary links to our magazine. I have, in fact, only posted one other (which the same user deleted for the same reason--and with whose decision I disagree for the same reason). In my short time so far with Wikipedia, I have also made other edits to articles and have posted links to other external sites with which I have no connection.
Wikipedia does not disallow posting links to anything at all with which you are connected. It disallows abuse in this area. I believe a reasonable litmus test is: If the poster weren't connected to the organization, would the link be valuable?
I contend, very strongly, yes. And the Wikipedia community and readers shouldn't be denied valuable information that fills in gaps just because I was the user who posted it.
I am very careful not to post links that are not intrinsically valuable. If I do violate that policy, I of course invite anyone to take me to task. But could I please get some feedback on this issue? I would like to repost the link.
Thank you.
MyFamilyDoctorMag ( talk) 22:22, 21 March 2008 (UTC)
MyFamilyDoctorMag ( talk) 05:02, 22 March 2008 (UTC)
MyFamilyDoctorMag ( talk) 21:41, 22 March 2008 (UTC)
It is confusing to read these one after the other in just 2 paragraphs:
"A 2006 review found that although it is safe for short term use (of three months or less), there is "no evidence that melatonin is effective in treating secondary sleep disorders or sleep disorders accompanying sleep restriction, such as jet lag and shiftwork disorder."
X
"It appears to have some use against other circadian rhythm sleep disorders as well, such as jet lag and the problems of people who work rotating or night shifts."
IIIIIIIII (
talk) 00:01, 19 December 2012 (UTC)
In addition, http://www.ncbi.nlm.nih.gov/pubmed/12076414 concludes "Melatonin is remarkably effective in preventing or reducing jet-lag [details omitted]" Who to believe? Yoyo Wing ( talk) 05:25, 17 March 2015 (UTC)
I am confused by the statement "Melatonin regulates leptin, lowering it" when the article on Leptin says it is high at night, possibly lowering appetite during sleep. In fact I find contradictions is nearly every article I read involving regulation of one hormone or neuro-transmitter by another. It seems to be a confused mess. RDXelectric ( talk) 23:54, 14 July 2017 (UTC)
This article seems to be overwhelmed with Exogenous and Medical uses. Couldn't these go in a separate article? I don't know if that's practical, but maybe something to discuss? Zyxwv99 ( talk) 22:52, 15 November 2015 (UTC)
http://www.nlm.nih.gov/medlineplus/druginfo/natural/940.html#DrugInteractions - link returns 404. <<== unsigned edit by IP 63.87.61.109
Although I cannot quote any reliable sources, Melatonin tablets are freely sold across most of Eastern Europe. There is also an sublingual composition marketed as Somni-X. It is a fast onset spray, applied under the tongue. -- lasombra bg ( talk) 21:45, 16 September 2016 (UTC)
That Melatonin acts as a neurotransmitter is implicit on this page in that it's part of the "neurotransmitters" series, and also that the *effects* of Melatonin receptors being engaged is described in the "Functions" section, however it is never clearly stated. See: Serotonin page functions section. -- Whilom Chime ( talk) 17:09, 4 December 2016 (UTC)
Here's the article: https://www.ncbi.nlm.nih.gov/pubmed/28648359 I don't want to edit the part of the article which says that there's not enough evidence for this myself owing to my very limited knowledge of such subjects, but perhaps that should be done if that review article is right. Dakane2 ( talk) 19:37, 23 January 2018 (UTC)
There are quite a few side effects listed under medical uses. Perhaps these categories should simoly be combined into "Medical uses and side effects". Dig deeper talk 04:11, 1 March 2018 (UTC)
@ Emh975: Can you proofread what you added? There's grammar mistakes and omissions (e.g., the bioavailability statement says "is between to and 50%" and doesn't specify a route of administration). Also, can you move the content you added in Melatonin#Pharmacodynamics to Melatonin#Biosynthesis and Melatonin#Regulation? Also, keep in mind that some of what you added is already covered there. Seppi333 ( Insert 2¢) 20:13, 29 January 2019 (UTC)
IMO this is better "Melatonin is a hormone, produced primarily by the pineal gland, which regulates wakefulness"
Than "Melatonin is a hormone and free radical scavenger that regulates sleep-wake cycles and functions as a mitochondrial antioxidant"
The ref is not very definitive says "targeted to the mitochondria where it seems to function as an apex antioxidant" [1]
And this ref "Evidence has emerged to show that both mitochondria and chloroplasts may have the capacity to synthesize and metabolize melatonin." [2]
Hardly definitive and as such IMO belongs lower in the body. Doc James ( talk · contribs · email) 02:38, 1 February 2019 (UTC)
User:Circleofpink This article is not about have sleep disorder are or are not a "grave public health crisis"...
There are also concerns that Frontiers is a predatory publisher.
And we already discuss sleep disorders with better references. Why a 2004 review when 2015 AHRQ reviews are avaliable? Doc James ( talk · contribs · email) 11:47, 24 January 2020 (UTC)
Somnipathy, or sleep disorders, are a familiar yet grave public health crisis that can be addressed with timely and effective pharmacological and/or non-pharmacological – and sometimes a combination of the two – treatments. [1] With the disadvantage of poor compliance to traditional pharmacological therapy coupled with the increasing complexity of multifaceted non-drug sleep therapies to suit individual needs, the exogenous administration of melatonin – an endogenous, naturally-produced hormone in the human body involved in sleep regulation – is looked at as a potential solution to secondary somnipathy, sleep disorders caused by another existing medical or psychological condition. [1] Melatonin has long been used to treat various insomnias (problems with falling and/or staying asleep) and delayed sleep phase disorder. [2] In 2004, a review of 30 randomized-controlled trial studies revealed that specifically to secondary sleep disorders, melatonin did not significantly have any effect neither on sleep onset latency (SOL), on wake after sleep onset (WASO), nor on the percentage of time spent in REM sleep. [3] However, melatonin did significantly increase sleep efficiency and total sleep time (TST) in people with secondary sleep disorders. [3]
References
And we provide a better summary of the evidence. Doc James ( talk · contribs · email) 11:47, 24 January 2020 (UTC)
Hypothalamic nuclei, such as the suprachiasmatic nuclei and the lateral hypothalamic area, that are affected by β-amyloid plaques and neurofilament tangles in brains with Alzheimer's diseases are also involved in the severe disruption of the circadian rhythm and consequently, the occurrence of sleep disorders. [1] Sleep disturbances as well as poor sleep quality may contribute to the development of Alzheimer's disease, to some degree through the facilitation of β-amyloid buildup (a risk factor for Alzheimer's disease) in the human brain. [2] [3] Research shows that in the pre-onset stages of Alzheimer's disease, melatonin levels in the CSF are significantly lower. [1] Furthermore, there is evidence in transgenic animal models of Alzheimer's disease that the exogenous administration of melatonin not only decreases the production and/or deposition of β-amyloid peptide but also increases its clearance through the glymphatic system. [4] Recent research concluded that exogenous melatonin administered in the preclinical phase of dementia demonstrates a significant increase in sleep quality and efficiency. [1]
References
The ordering of this article follows WP:MEDMOS and has for some time. So restored. Doc James ( talk · contribs · email) 16:44, 29 March 2020 (UTC)
"Melatonin is rapidly absorbed and distributed, reaching peak plasma concentrations after 60 minutes of administration, and is then eliminated. Melatonin has a half life of 35–50 minutes."
How does that work? — Preceding unsigned comment added by Drsruli ( talk • contribs) 14:47, 22 July 2019 (UTC)
I think that the section should be removed. — Preceding unsigned comment added by 97.113.124.116 ( talk) 05:47, 3 August 2020 (UTC) I agree that the research is too preliminary for an encyclopedia article and I deleted the entire section. Tachyon ( talk) 12:38, 3 August 2020 (UTC)
This article could do with a bit of a reorganization: it moves freely from talking about naturally occurring melatonin to talking about melatonin taken as a sleep aid/dietary supplement. It's generally clear from context that, for example, the safety section is about the supplement... but other parts aren't as clear. -- Starwed 05:23, 1 October 2007 (UTC)
In the section on “biological clock” I intend to add this sentence immediately following “but over-illumination can create significant reduction in melatonin production.”; “Since it is blue light that suppresses melatonin (ref. 1) , wearing glasses that block blue light (ref. 2)in the evening can help maintain melatonin production.” The first reference is to Brainard’s 2001 paper PMID: 11487664 that identifies blue light as the cause of melatonin suppression and the second reference is to Kayumov’s paper PMID: 15713707 in which he showed glasses that block blue light allow melatonin to flow, despite exposure to bright light. Are there any objections to my doing so? Rhansler 13:54, 2 November 2007 (UTC) Rhansler
In view of the above I think I will add a qualifying word along with blue light to read "principally blue light". Rhansler Rhansler 02:41, 5 November 2007 (UTC) Rhansler —Preceding unsigned comment added by Rhansler ( talk • contribs) 21:39, 4 November 2007 (UTC)
If I put in in this format will it work? Since it is principally blue light that suppresses melatonin PMID: 11487664, wearing glasses that block blue light PMID: 15713707 in the hours before bedtime can help maintain melatonin production. Rhansler 18:26, 6 November 2007 (UTC) Rhansler
I feel that this section is oddly misplaced at the end instead of near the beginning of the article. Melatonin plays a tremendous role wrt seasonality, reproduction etc in many animals. The section looks like an afterthought. It would IMO be better moved to right after Production and Distribution.
Its name is perhaps a bit odd, too. Role in the study of zoology, or role in the animal kingdom? Hordaland 09:43, 5 November 2007 (UTC)
The John Hammell reference may be seriously meant, but it reads like a parody. The following article from The Independent may be a better (as well as newer) source: http://news.independent.co.uk/health/article118214.ece Hordaland 18:35, 8 November 2007 (UTC)
The primary basic funtion of melatonin is not that of an anti-oxidant. Many related molecules can exert similar anti-oxidant activity (Proc Natl Acad Sci U S A. 1990 Apr;87(7):2506-10. Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases.Christen S, Peterhans E, Stocker R.
The basic melatonin function is to tell the body the time of the day and of the year by acting on high affinity receptors. Accordin to the existing evidence, melatonin is just one of the many anti-oxidant molecules —Preceding unsigned comment added by 193.246.191.129 ( talk) 13:54, 22 November 2007 (UTC)
A paragraph, see below, was recently added to the Biological Clock (in humans) section about melatonin's effect on the hormone Leptin and on appetite. This was sadly misplaced. I added a short mention of and link to Leptin in the section on the animal kingdom and added (moved) the reference to the article on Leptin. If more of the removed paragraph should appear in the Melatonin article, it should be added in a relevant section. The removed paragraph was this:
Affects on Appetite: Leptin is a hormone that is synthesized in adipose tissue that is produced in direct proportion to fat stores within the body. Elevated levels of serum leptin result in a decrease in appetite. Melatonin receptors have been found in adipose tissue which, upon stimulation by melatonin acting in concert with insulin, increase production of leptin (Alonso-Vale, M.I., Andreotti, S., Peres, S.B., Anhe, G.F., Borges-Silva, C.N., Neto, J.C. & Lima, F.B. (2004). American Journal of Physiology-Endocrinology and Metabolism: November 30, 2004. Retrieved Dec. 15, 2007 from http://ajpendo.physiology.org/cgi/content/short/00478.2004v1.). Therfore, the net effect is that elevated levels of melatonin decrease appetite. —Preceding unsigned comment added by Hordaland ( talk • contribs) 22:55, 15 December 2007 (UTC)
It would be good if someone could find a source for this. The article said that melatonin was not available over-the-counter in the EU. An anon has recently changed this, commenting "Melatonin is sold OTC in many EU countries". I know that it's not OTC in Sweden nor UK. How to find out if there's an EU policy on this? Or a listing of other countries outside of EU? -- Hordaland ( talk) 19:20, 5 January 2008 (UTC)
Yes, As far as I know it is not OTC in the UK. SpangleJ - UK
Spanglej (
talk) 20:19, 5 April 2009 (UTC)
The article mentions that tinted glasses can be worn in order to promote melatonin production. I believe, however, that the melatonin-light interaction occurs in all the skin, so mostly has nothing to do with the eyes. Would someone with more knowledge confirm or deny my suspicion? —Preceding unsigned comment added by 75.31.242.30 ( talk) 04:30, 6 January 2008 (UTC)
This article is now the new Pharmacology Collaboration of the Month. Hopefully, it can be improved to featured or good article status. Dr. Cash ( talk) 17:32, 14 January 2008 (UTC)
Melatonin taken in combination with monoamine oxidase inhibitors (MAOIs) can lead to overdose because MAOIs inhibit the breakdown of melatonin by the body.[citation needed]
Removing this sentence. It's been discussed since 12/05 December 2005 (see above archive), and still no source. It's also not entirely clear on overdose of what? Overdosing on melatonin is unheard of. --
Hordaland (
talk) 00:01, 17 January 2008 (UTC)
The International Agency for Research on Cancer, announced through a press release in December 2007 that shiftwork that involves circadian disruption is “probably carcinogenic to humans”.
They reviewed epidemiological studies of long-term female night shiftworkers and noted a higher risk of breast cancer risk than those who did not work at night. These studies have involved mainly nurses and flight attendants. Animal studies had similar results where light at night significantly increased tumours. This relates to melatonin in that studies reducing levels of this hormone at night increased the tumours.
The IARC committee head noted that nearly 20% of the working population in Europe and North America are engaged in shiftwork, with many workers in health-care and transportation fiels as well as in industrial, communications, and hospitality sectors. Studies focussed on breast cancer in nurses and flight attendants.
70.51.93.236 ( talk) 00:16, 24 February 2008 (UTC)Lorraine Davison 70.51.93.236 ( talk) 00:16, 24 February 2008 (UTC)
{{
cite journal}}
: Unknown parameter |coauthors=
ignored (|author=
suggested) (
help)"Until recent history, humans in temperate climates were exposed to up to 18 hours of darkness in the winter" Didn't people gather around camp fires for lighting and warmth in the winter? -- Phenylalanine ( talk) 21:08, 1 March 2008 (UTC)
Greetings,
I posted an external link and it was deleted. I would respectfully like to request feedback on this.
The link was on melatonin and insomnia.
I felt it was valuable because the article to which I linked:
The user who deleted it said it "Violates WP:COI, WP:ADVERT, etc." I understand this point of view but respectfully disagree with it. I am connected with the magazine that published the article, but I am not going around posting arbitrary links to our magazine. I have, in fact, only posted one other (which the same user deleted for the same reason--and with whose decision I disagree for the same reason). In my short time so far with Wikipedia, I have also made other edits to articles and have posted links to other external sites with which I have no connection.
Wikipedia does not disallow posting links to anything at all with which you are connected. It disallows abuse in this area. I believe a reasonable litmus test is: If the poster weren't connected to the organization, would the link be valuable?
I contend, very strongly, yes. And the Wikipedia community and readers shouldn't be denied valuable information that fills in gaps just because I was the user who posted it.
I am very careful not to post links that are not intrinsically valuable. If I do violate that policy, I of course invite anyone to take me to task. But could I please get some feedback on this issue? I would like to repost the link.
Thank you.
MyFamilyDoctorMag ( talk) 22:22, 21 March 2008 (UTC)
MyFamilyDoctorMag ( talk) 05:02, 22 March 2008 (UTC)
MyFamilyDoctorMag ( talk) 21:41, 22 March 2008 (UTC)
It is confusing to read these one after the other in just 2 paragraphs:
"A 2006 review found that although it is safe for short term use (of three months or less), there is "no evidence that melatonin is effective in treating secondary sleep disorders or sleep disorders accompanying sleep restriction, such as jet lag and shiftwork disorder."
X
"It appears to have some use against other circadian rhythm sleep disorders as well, such as jet lag and the problems of people who work rotating or night shifts."
IIIIIIIII (
talk) 00:01, 19 December 2012 (UTC)
In addition, http://www.ncbi.nlm.nih.gov/pubmed/12076414 concludes "Melatonin is remarkably effective in preventing or reducing jet-lag [details omitted]" Who to believe? Yoyo Wing ( talk) 05:25, 17 March 2015 (UTC)
I am confused by the statement "Melatonin regulates leptin, lowering it" when the article on Leptin says it is high at night, possibly lowering appetite during sleep. In fact I find contradictions is nearly every article I read involving regulation of one hormone or neuro-transmitter by another. It seems to be a confused mess. RDXelectric ( talk) 23:54, 14 July 2017 (UTC)
This article seems to be overwhelmed with Exogenous and Medical uses. Couldn't these go in a separate article? I don't know if that's practical, but maybe something to discuss? Zyxwv99 ( talk) 22:52, 15 November 2015 (UTC)
http://www.nlm.nih.gov/medlineplus/druginfo/natural/940.html#DrugInteractions - link returns 404. <<== unsigned edit by IP 63.87.61.109
Although I cannot quote any reliable sources, Melatonin tablets are freely sold across most of Eastern Europe. There is also an sublingual composition marketed as Somni-X. It is a fast onset spray, applied under the tongue. -- lasombra bg ( talk) 21:45, 16 September 2016 (UTC)
That Melatonin acts as a neurotransmitter is implicit on this page in that it's part of the "neurotransmitters" series, and also that the *effects* of Melatonin receptors being engaged is described in the "Functions" section, however it is never clearly stated. See: Serotonin page functions section. -- Whilom Chime ( talk) 17:09, 4 December 2016 (UTC)
Here's the article: https://www.ncbi.nlm.nih.gov/pubmed/28648359 I don't want to edit the part of the article which says that there's not enough evidence for this myself owing to my very limited knowledge of such subjects, but perhaps that should be done if that review article is right. Dakane2 ( talk) 19:37, 23 January 2018 (UTC)
There are quite a few side effects listed under medical uses. Perhaps these categories should simoly be combined into "Medical uses and side effects". Dig deeper talk 04:11, 1 March 2018 (UTC)
@ Emh975: Can you proofread what you added? There's grammar mistakes and omissions (e.g., the bioavailability statement says "is between to and 50%" and doesn't specify a route of administration). Also, can you move the content you added in Melatonin#Pharmacodynamics to Melatonin#Biosynthesis and Melatonin#Regulation? Also, keep in mind that some of what you added is already covered there. Seppi333 ( Insert 2¢) 20:13, 29 January 2019 (UTC)
IMO this is better "Melatonin is a hormone, produced primarily by the pineal gland, which regulates wakefulness"
Than "Melatonin is a hormone and free radical scavenger that regulates sleep-wake cycles and functions as a mitochondrial antioxidant"
The ref is not very definitive says "targeted to the mitochondria where it seems to function as an apex antioxidant" [1]
And this ref "Evidence has emerged to show that both mitochondria and chloroplasts may have the capacity to synthesize and metabolize melatonin." [2]
Hardly definitive and as such IMO belongs lower in the body. Doc James ( talk · contribs · email) 02:38, 1 February 2019 (UTC)
User:Circleofpink This article is not about have sleep disorder are or are not a "grave public health crisis"...
There are also concerns that Frontiers is a predatory publisher.
And we already discuss sleep disorders with better references. Why a 2004 review when 2015 AHRQ reviews are avaliable? Doc James ( talk · contribs · email) 11:47, 24 January 2020 (UTC)
Somnipathy, or sleep disorders, are a familiar yet grave public health crisis that can be addressed with timely and effective pharmacological and/or non-pharmacological – and sometimes a combination of the two – treatments. [1] With the disadvantage of poor compliance to traditional pharmacological therapy coupled with the increasing complexity of multifaceted non-drug sleep therapies to suit individual needs, the exogenous administration of melatonin – an endogenous, naturally-produced hormone in the human body involved in sleep regulation – is looked at as a potential solution to secondary somnipathy, sleep disorders caused by another existing medical or psychological condition. [1] Melatonin has long been used to treat various insomnias (problems with falling and/or staying asleep) and delayed sleep phase disorder. [2] In 2004, a review of 30 randomized-controlled trial studies revealed that specifically to secondary sleep disorders, melatonin did not significantly have any effect neither on sleep onset latency (SOL), on wake after sleep onset (WASO), nor on the percentage of time spent in REM sleep. [3] However, melatonin did significantly increase sleep efficiency and total sleep time (TST) in people with secondary sleep disorders. [3]
References
And we provide a better summary of the evidence. Doc James ( talk · contribs · email) 11:47, 24 January 2020 (UTC)
Hypothalamic nuclei, such as the suprachiasmatic nuclei and the lateral hypothalamic area, that are affected by β-amyloid plaques and neurofilament tangles in brains with Alzheimer's diseases are also involved in the severe disruption of the circadian rhythm and consequently, the occurrence of sleep disorders. [1] Sleep disturbances as well as poor sleep quality may contribute to the development of Alzheimer's disease, to some degree through the facilitation of β-amyloid buildup (a risk factor for Alzheimer's disease) in the human brain. [2] [3] Research shows that in the pre-onset stages of Alzheimer's disease, melatonin levels in the CSF are significantly lower. [1] Furthermore, there is evidence in transgenic animal models of Alzheimer's disease that the exogenous administration of melatonin not only decreases the production and/or deposition of β-amyloid peptide but also increases its clearance through the glymphatic system. [4] Recent research concluded that exogenous melatonin administered in the preclinical phase of dementia demonstrates a significant increase in sleep quality and efficiency. [1]
References
The ordering of this article follows WP:MEDMOS and has for some time. So restored. Doc James ( talk · contribs · email) 16:44, 29 March 2020 (UTC)
"Melatonin is rapidly absorbed and distributed, reaching peak plasma concentrations after 60 minutes of administration, and is then eliminated. Melatonin has a half life of 35–50 minutes."
How does that work? — Preceding unsigned comment added by Drsruli ( talk • contribs) 14:47, 22 July 2019 (UTC)
I think that the section should be removed. — Preceding unsigned comment added by 97.113.124.116 ( talk) 05:47, 3 August 2020 (UTC) I agree that the research is too preliminary for an encyclopedia article and I deleted the entire section. Tachyon ( talk) 12:38, 3 August 2020 (UTC)